At Least 82 Dead in China Coal Mine Blast Worst Disaster in 16 Years
Nvidia Boosts Dividend and Buybacks as Free Cash Flow Surges Is NVDA Undervalued
China Coal Mine Blast in Shanxi Kills at Least 82 Worst Disaster in 16 Years
Jim Cramers Ongoing Investigation of Adobe Sparks Market Interest
Oil Plunges as US Stocks Hit New Highs Could Bitcoin Follow the SP 500 Rally
Legal IP Challenges in Smart Manufacturing Data Ownership Trade Secrets and AI Patent Trends
NTRA Q1 2026 Earnings EPS Misses Estimates as Revenue Unreported Stock Slightly Down
Westrock Coffee Company Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions
GYRE Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Surprise Amid Revenue Absence
ALGS Q1 2026 Earnings NarrowerthanExpected Loss as Aligos Therapeutics Advances Pipeline
Oxford Industries Q1 2026 Earnings Earnings Miss Widens Despite Stock Rally
Rallybio Corporation Q1 2026 Earnings Wider Loss Reflects RD Investment Stock Gains
AGNC Investment Corp Eases Slightly Holding Near Established Support Level
Callan JMB Inc CJMB Edges Higher as Consolidation Near Support Continues
Gladstone Investment Notes GAING Hold Steady Near Par Amid Rate Uncertainty
SC II Acquisition Corp Edges Higher Amid Light Trading Near Key Support
Clearfield Inc CLFD Surges 9 FiberOptic Momentum Drives Breakout Above Key Support
BellRing Brands BRBR Q1 2026 Earnings EPS Miss of 565 Triggers Slight Stock Decline
Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress
SBH Q1 2026 Earnings EPS Beats Estimates Amid Corporate Transition
RYAM Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement
FNLC Q1 2026 Earnings Modest Performance Amid Narrowing Margins
authID Q1 2026 Earnings Narrowing Operating Loss Despite PreRevenue Status
Q4 Results Roundup Graphite India Posts Loss Alkem Lab and Anup Engineering Profit Drops Multiple Companies Announce Earnings
CLNN Q1 2026 Earnings Significant EPS Beat Despite PreRevenue Status and Stock Decline
Redhill Biopharma RDHL Holds Steady at 101 as Key Levels Define Trading Range